Guided Therapeutics (GTHP) Other Working Capital Changes (2011 - 2025)
Guided Therapeutics (GTHP) reported Other Working Capital Changes of -$22000.0 for Q4 2025, up 12.0% on a YoY basis from -$19642.9 in Q4 2024, and up 18.52% sequentially from -$27000.0 in Q3 2025.
Guided Therapeutics (GTHP) Other Working Capital Changes (2011 - 2025) Analysis & Trends
Guided Therapeutics (GTHP) has 6 years of Other Working Capital Changes data on file, last reported at -$22000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Working Capital Changes rose 12.0% year-over-year to -$22000.0; the trailing twelve-month figure through Dec 2025 stood at -$100000.0 (down 8.7% YoY), and the FY2025 full-year result was -$100000.0, down 8.7% from the prior year.
- Other Working Capital Changes improved to -$22000.0 in Q4 2025, from -$27000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $507000.0 in Q4 2024 to a low of -$507000.0 in Q3 2022.
- A 5-year average of $8222.2 and a median of -$8000.0 in 2023 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes jumped 53.66% in 2022 and plunged 31.25% in 2023, its largest moves.
- Tracing GTHP's Other Working Capital Changes over 5 years: stood at -$15000.0 in 2021, then fell by 6.67% to -$16000.0 in 2022, then sank by 31.25% to -$21000.0 in 2023, then fell by 19.05% to -$25000.0 in 2024, then grew by 12.0% to -$22000.0 in 2025.
- Business Quant data shows GTHP's Other Working Capital Changes at -$22000.0 in Q4 2025, -$27000.0 in Q3 2025, and -$26000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Guided Therapeutics | 21.96 Mn | 21.89 Mn | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -485,000.00 |
| Dec 31, 2025 | -485,000.00 |
| Dec 31, 2025 | -485,000.00 |
| Sep 30, 2025 | -5,000.00 |
| Sep 30, 2025 | -5,000.00 |
| Sep 30, 2025 | -5,000.00 |
| Jun 30, 2025 | -59,000.00 |
| Jun 30, 2025 | -59,000.00 |
| Jun 30, 2025 | -59,000.00 |
| Mar 31, 2025 | -111,000.00 |
| Mar 31, 2025 | -111,000.00 |
| Mar 31, 2025 | -111,000.00 |
| Dec 31, 2024 | 507,000.00 |
| Dec 31, 2024 | 507,000.00 |
| Dec 31, 2024 | 507,000.00 |
| Sep 30, 2024 | -406,000.00 |
| Sep 30, 2024 | -406,000.00 |
| Sep 30, 2024 | -406,000.00 |
| Mar 31, 2024 | 324,000.00 |
| Mar 31, 2024 | 324,000.00 |